Eurofins Scientific SE
ERF
Clasificación en acciones
#1376
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Precio por acción
$93.33
Capitalización bursátil
$16.20B
Cambio (1 día)
-0.33%
Cambio (1 año)
25.44%
País
LU
Comercio Eurofins Scientific SE (ERF)
Categoría
Healthcare
Ganancias de Eurofins Scientific SE (ERF)
Ganancias en Jun 2026 TTM: $862.10M
Secondo gli ultimi rapporti finanziari di Eurofins Scientific SE, gli utili attuali della società sono $862.10M. Nel 2024, la società ha registrato un utile di $577.10M, un aumento con respecto a agli utili del 2023, che erano di $467.94M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Eurofins Scientific SE desde 2002 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $862.10M | 12.35% |
| 2025 | $767.32M | 32.96% |
| 2024 | $577.10M | 23.33% |
| 2023 | $467.94M | -44.07% |
| 2022 | $836.69M | -30.36% |
| 2021 | $1.20B | 42.07% |
| 2020 | $845.69M | 177.62% |
| 2019 | $304.62M | -8.54% |
| 2018 | $333.07M | 10.99% |
| 2017 | $300.10M | 17.56% |
| 2016 | $255.27M | 77.62% |
| 2015 | $143.72M | 17.22% |
| 2014 | $122.61M | 0.11% |
| 2013 | $122.48M | 13.68% |
| 2012 | $107.74M | 18.11% |
| 2011 | $91.22M | 88.59% |
| 2010 | $48.37M | -1,720.16% |
| 2009 | $-2.99M | -107.78% |
| 2008 | $38.37M | -9.89% |
| 2007 | $42.58M | 4.56% |
| 2006 | $40.72M | 46.24% |
| 2005 | $27.85M | 72.80% |
| 2004 | $16.11M | 196.15% |
| 2003 | $5.44M | 145.28% |
| 2002 | $2.22M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $7.61B | 782.61% |
US
|
|
| $4.76B | 452.37% |
US
|
|
| $-252.70M | -129.31% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 92.32% |
US
|
